ZA905735B - Method for stimulating proliferation of peripheral blood lymphocytes - Google Patents
Method for stimulating proliferation of peripheral blood lymphocytesInfo
- Publication number
- ZA905735B ZA905735B ZA905735A ZA905735A ZA905735B ZA 905735 B ZA905735 B ZA 905735B ZA 905735 A ZA905735 A ZA 905735A ZA 905735 A ZA905735 A ZA 905735A ZA 905735 B ZA905735 B ZA 905735B
- Authority
- ZA
- South Africa
- Prior art keywords
- peripheral blood
- blood lymphocytes
- stimulating proliferation
- stimulating
- proliferation
- Prior art date
Links
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 title 1
- 230000035755 proliferation Effects 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464402—Receptors, cell surface antigens or cell surface determinants
- A61K39/464411—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38394289A | 1989-07-21 | 1989-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA905735B true ZA905735B (en) | 1992-03-25 |
Family
ID=23515405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA905735A ZA905735B (en) | 1989-07-21 | 1990-07-20 | Method for stimulating proliferation of peripheral blood lymphocytes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0409655A3 (xx) |
JP (1) | JP3056230B2 (xx) |
AU (1) | AU633940B2 (xx) |
CA (1) | CA2021500C (xx) |
GR (1) | GR1001034B (xx) |
IE (1) | IE902662A1 (xx) |
ZA (1) | ZA905735B (xx) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2981486B2 (ja) * | 1988-06-14 | 1999-11-22 | メディカル・バイオロジー・インスティチュート | 哺乳動物の免疫系研究方法 |
WO1992017567A1 (en) * | 1991-04-05 | 1992-10-15 | Regents Of The University Of Minnesota | Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets |
US5725855A (en) * | 1991-04-05 | 1998-03-10 | The United States Of America As Represented By The Department Of Health And Human Services | Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations |
IE922233A1 (en) * | 1991-07-10 | 1993-01-13 | Augusto C Ochoa | Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity |
WO1995032729A1 (en) * | 1994-05-31 | 1995-12-07 | Augusto Carlos Ochoa | Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
AU2387697A (en) * | 1996-04-17 | 1997-11-07 | Boehringer Mannheim Gmbh | Process for producing and multiplying lymphocytes |
US6511848B2 (en) | 1996-04-17 | 2003-01-28 | Winfried Albert | Process for producing and multiplying lymphocytes |
JP4186013B2 (ja) * | 1996-07-15 | 2008-11-26 | 暉彬 関根 | ウイルス感染症の治療・予防剤、その調製方法 |
SE511143C2 (sv) | 1997-12-30 | 1999-08-09 | Sca Hygiene Paper Ab | Metod att framställa ett papper uppvisande en tredimensionellt mönster |
JP2001354575A (ja) | 2000-06-09 | 2001-12-25 | Human Tekku:Kk | 癌の再発予防法および癌の再発予防用活性化リンパ球を含む製剤、ならびにそれらの細胞の凍結および加工委・受託システム |
JP4917201B2 (ja) * | 2000-12-04 | 2012-04-18 | 株式会社リンフォテック | 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。 |
CA2439811A1 (en) * | 2001-03-05 | 2002-09-12 | Lymphotec Inc. | Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt |
DE10120505A1 (de) * | 2001-04-26 | 2002-11-07 | Rudolf Wank | Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von Krebserkrankungen |
ATE491021T1 (de) | 2002-03-25 | 2010-12-15 | Takara Bio Inc | Verfahren zur produktion eines zytotoxischen lymphozyten |
JP4562353B2 (ja) * | 2002-04-08 | 2010-10-13 | 株式会社リンフォテック | Hla一致他人由来活性化リンパ球を含有してなる腫瘍・感染症および自己免疫疾患の予防・治療用製剤 |
US20070025961A1 (en) * | 2003-06-03 | 2007-02-01 | Kenzo Bamba | Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
EP1666589B1 (en) | 2003-08-22 | 2010-02-17 | Takara Bio Inc. | Process for producing cytotoxic lymphocytes |
JP2006143709A (ja) * | 2004-10-20 | 2006-06-08 | Lymphotec:Kk | 薬剤耐性原生生物感染症の治療もしくは予防用製剤、該製剤の調製用キットおよび調製方法、薬剤耐性原生生物感染症の治療方法 |
KR101279172B1 (ko) * | 2005-08-17 | 2013-06-27 | 다카라 바이오 가부시키가이샤 | 림프구의 제조 방법 |
EP2390361A1 (en) * | 2006-06-02 | 2011-11-30 | GlaxoSmithKline Biologicals SA | Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the IL7R gene |
KR101133185B1 (ko) * | 2008-07-29 | 2012-04-06 | 서울대학교병원 | 자연살해세포의 증식방법 |
WO2018124119A1 (ja) * | 2016-12-27 | 2018-07-05 | 住友化学株式会社 | 染色体の異常の検出方法および誘発性を評価する方法 |
MY197176A (en) | 2018-02-01 | 2023-05-30 | Nkmax Co Ltd | Method of producing natural killer cells and composition for treating cancer |
US20220403002A1 (en) | 2019-11-01 | 2022-12-22 | Kyoto Prefectural Public University Corporation | B-cell antibody receptor and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE82588T1 (de) * | 1986-04-28 | 1992-12-15 | Endotronics Inc | Zuchtverfahren fuer leukocyten. |
WO1988000970A2 (en) * | 1986-08-08 | 1988-02-11 | Regents Of The University Of Minnesota | Method of culturing leukocytes |
DE3634017A1 (de) * | 1986-10-06 | 1988-04-14 | Max Planck Gesellschaft | Verfahren zur aktivierung und vermehrung von t-zellen, insbesondere von deren subpopulationen |
AU4485089A (en) * | 1988-10-21 | 1990-05-14 | Brigham And Women's Hospital | Activation and growth of human tumor-infiltrating lymphocytes using antibodies to cd3 or tcr |
-
1990
- 1990-07-18 GR GR900100551A patent/GR1001034B/el not_active IP Right Cessation
- 1990-07-19 CA CA002021500A patent/CA2021500C/en not_active Expired - Lifetime
- 1990-07-20 ZA ZA905735A patent/ZA905735B/xx unknown
- 1990-07-20 IE IE266290A patent/IE902662A1/en unknown
- 1990-07-20 AU AU59182/90A patent/AU633940B2/en not_active Ceased
- 1990-07-20 EP EP19900307983 patent/EP0409655A3/en not_active Withdrawn
- 1990-07-20 JP JP2190897A patent/JP3056230B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU633940B2 (en) | 1993-02-11 |
CA2021500A1 (en) | 1991-01-22 |
JPH0380076A (ja) | 1991-04-04 |
JP3056230B2 (ja) | 2000-06-26 |
GR900100551A (xx) | 1991-12-10 |
GR1001034B (el) | 1993-03-31 |
AU5918290A (en) | 1991-01-24 |
EP0409655A2 (en) | 1991-01-23 |
IE902662A1 (en) | 1991-02-27 |
CA2021500C (en) | 1995-06-13 |
EP0409655A3 (en) | 1992-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0409655A3 (en) | Method for stimulating proliferation of peripheral blood lymphocytes | |
SU1670858A1 (ru) | Способ забора крови | |
GB8916394D0 (en) | Method of treatment | |
GB8928896D0 (en) | Method of treatment | |
GB8924155D0 (en) | Method of treatment | |
GB8920985D0 (en) | Method of treatment | |
GB8912935D0 (en) | Method of treatment | |
GB8912934D0 (en) | Method of treatment | |
GB8911258D0 (en) | Method of treatment | |
GB8906430D0 (en) | Method of treatment | |
GB8906429D0 (en) | Method of treatment | |
GB8906428D0 (en) | Method of treatment | |
GB8906427D0 (en) | Method of treatment | |
GB8906426D0 (en) | Method of treatment | |
GB8906425D0 (en) | Method of treatment | |
GB8906424D0 (en) | Method of treatment | |
GB8904258D0 (en) | Method of treatment | |
GB8929033D0 (en) | Method of treatment | |
ZA904464B (en) | Method of treatment using 17beta-cyclopropylaminoandrostene | |
BG47873A1 (en) | Method for expression of gene of human alpha- 1- interferon | |
GB8800565D0 (en) | Method of treatment | |
GB8801688D0 (en) | Method of treatment | |
GB8803008D0 (en) | Method of treatment | |
GB8804204D0 (en) | Method of treatment | |
GB8804206D0 (en) | Method of treatment |